dextroamphetamine has been researched along with Choreoathetosis Self-Mutilation Hyperuricemia Syndrome in 2 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wojcik, BE | 1 |
| Jinnah, HA | 2 |
| Muller-Sieburg, CE | 1 |
| Friedmann, T | 2 |
| Gage, FH | 1 |
2 other studies available for dextroamphetamine and Choreoathetosis Self-Mutilation Hyperuricemia Syndrome
| Article | Year |
|---|---|
Bone marrow transplantation does not ameliorate the neurologic symptoms in mice deficient in hypoxanthine guanine phosphoribosyl transferase (HPRT).
Topics: Animals; Behavior, Animal; Bone Marrow Transplantation; Dextroamphetamine; Disease Models, Animal; D | 1999 |
Amphetamine-induced behavioral phenotype in a hypoxanthine-guanine phosphoribosyltransferase-deficient mouse model of Lesch-Nyhan syndrome.
Topics: Animals; Brain; Catecholamines; Chromosome Deletion; Dextroamphetamine; Hypoxanthine Phosphoribosylt | 1991 |